Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 4)

Alzheimer Disease (Phase 2)

Arthritis, Juvenile (Phase 2)

Asthma (Phase 4)

Breast Neoplasms (Phase 2)

Coronary Disease (Phase 3)

Dementia (Phase 2)

Depression (Phase 1)

Depressive Disorder (Phase 1)

Depressive Disorder, Major (Phase 1)

Depressive Disorder, Treatment-Resistant (Phase 1)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Fatigue (Phase 2)

Glioblastoma (Phase 1)

Heart Failure (Phase 3)

Hypertension, Pulmonary (Phase 3)

Infarction (Phase 4)

Inflammation (Phase 4)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Lewy Body Disease (Phase 2)

Lung Neoplasms (Phase 2)

Mental Disorders (Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Myocardial Infarction (Phase 4)

Neonatal Sepsis (Phase 3)

Neoplastic Cells, Circulating (Phase 2)

Neutropenia (Phase 4)

Opioid-Related Disorders (Phase 3)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 3)

Parkinson Disease (Phase 2)

Pneumonia (Phase 4)

Postpoliomyelitis Syndrome (Phase 3)

Psychotic Disorders (Phase 2)

Purpura (Phase 3)

Purpura, Thrombocytopenic (Phase 3)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Renal Insufficiency (Phase 2)

Respiratory Sounds (Phase 4)

Respiratory Tract Infections (Phase 4)

Schizophrenia (Phase 2)

Sciatica (Phase 4)

Sclerosis (Phase 3)

Sjogren's Syndrome (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Still's Disease, Adult-Onset (Phase 2)

Syndrome (Phase 3)

Thrombocytopenia (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)